3D-printed nozzles could revolutionize drug and self-healing material manufacturing — MIT-developed triaxial electrospray design makes cleanroom fabrication optional
MIT's 3D-printed triaxial electrospray nozzles could revolutionize drug and self-healing material manufacturing. By using a relatively inexpensive resin printing approach, the new nozzle fabrication technique removes the need for a semiconductor-class cleanroom facility.
Advances in 3D printing technology, particularly with resin-based approaches, are enabling novel fabrication methods previously thought impractical or uneconomical outside highly controlled environments.
This development significantly lowers the barriers to entry for advanced manufacturing of complex micro-structures, making sophisticated production accessible to a wider range of industries and research institutions.
Manufacturing of micro-scale components for drug delivery and advanced materials, which traditionally required expensive cleanroom facilities, can now be achieved with more cost-effective 3D printing methods.
- · Pharmaceutical industry
- · Advanced materials manufacturers
- · Research institutions
- · 3D printing companies
- · Traditional cleanroom manufacturing facilities
- · Manufacturers of conventional electrospray nozzles
Reduced costs and increased speed in developing new drug delivery systems and self-healing materials.
Acceleration of R&D in fields requiring precise micro-fabrication, leading to new product categories and market opportunities.
Potential for localized, on-demand production of high-value components, decentralizing certain aspects of advanced manufacturing supply chains.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at Tom's Hardware